Description
Luxiq (betamethasone valerate) is a skin care and dermatology products agent listed in our Skin care and dermatology products directory and prescribed for specified inflammatory, itchy, or flaky skin conditions (1.1) (2.1). Administered via the topical route, Luxiq is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.
Luxiq is a medication containing the active pharmaceutical ingredient betamethasone valerate, classified pharmacologically as a skin care and dermatology products agent (2.1). It is clinically indicated for the management of specified inflammatory, itchy, or flaky skin conditions as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).
Within the Skin care and dermatology products section of our catalogue, patients and prescribers frequently review Luxiq alongside related therapies such as Betaderm (Betamethasone Valerate), Aczone (Dapsone), Adapalene, and Aklief (Trifarotene).
Official Indications and Usage
Indications and usage Betamethasone valerate foam, 0.12% is a medium potency topical corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp. (1.1)
Clinical Pharmacology
Clinical pharmacology Like other topical corticosteroids, betamethasone valerate foam has anti-inflammatory, antipruritic, and vasoconstrictive properties. The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A 2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A 2. (1.1)
Ordering Luxiq from Canada for U.S. Delivery
U.S. patients can order Luxiq (Betamethasone) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.
Step 1
Send Your Prescription
- Valid Rx required from a U.S.-licensed physician, NP, or PA (Rx rules).
- Upload Rx online, request a pharmacy transfer, or have your doctor fax (844) 666 – 6819.
- Order up to a 90-day personal-use supply per shipment (refill planning).
Step 2
Pharmacist Safety Check
- Multi-point dosing and interaction review completed in under 1 business day.
- Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
- Verified under our Pharmacy Safety Standards.
Step 3
$14.99 USD Tracked Parcel
- Packed in discreet protective packaging for a flat $14.99 USD per order ($29.99 if combined with cold-chain).
- Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
- Review full shipping and delivery details.
Step 4
U.S. Street Delivery & Payment
- Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
- You see and approve the country of origin upfront before your card is charged.
- Report any delayed or damaged parcel within 48 hours for prompt resolution.
Fact Table
| Clinical Specification | Details |
|---|---|
| Brand / Product Name | Luxiq |
| Chemical / Generic Name | Betamethasone Valerate |
| Pharmacological Class | Skin care and dermatology products agent |
| Therapeutic Category | Skin care and dermatology products |
| Same-Ingredient Catalogue Entries | Betaderm (Betamethasone Valerate) |
| Molecular Weight | 476.58. g/mol (2.1) |
| Legal Status | Rx-Only (Prescription Required) |
| Regulatory Reference Authorities | U.S. FDA (DailyMed), Health Canada (DPD) |
| Routes of Administration | Topical |
| Primary Indications | Specified Inflammatory, Itchy, Or Flaky Skin Conditions |
| Pregnancy & Breastfeeding | Consult Doctor / Prescriber before use |
| FDA UNII Identifier | 9IFA5XM7R2 |
| NLM RxNorm Concept ID (RxCUI) | 1244634 |
| FDA Application License | ANDA208204 |
| Official DailyMed SetID | 7c96b978-25ff-44c2-bc9c-30ff5e34cffb |
| Catalogue Index Links | Letter L Index · All Medications · All Categories |
Directions
Dosage and Administration Overview
Dosage and administration Note: For proper dispensing of foam, can must be inverted. For application to the scalp invert can and dispense a small amount of betamethasone valerate foam, 0.12% onto a saucer or other cool surface. Do not dispense directly onto hands as foam will begin to melt immediately upon contact with warm skin. Pick up small amounts of foam with fingers and gently massage into affected area until foam disappears. Repeat until entire affected scalp area is treated. (1.1)
Administration Guidance
Apply Luxiq to the affected area in a thin layer as directed by your prescriber (1.1). Wash hands before and after application (unless treating the hands), avoid contact with the eyes or mucous membranes, and do not cover with occlusive dressings unless specifically instructed by your physician.
Missed Dose Guidance
If you miss a scheduled dose of Luxiq, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).
Ingredients
Active Pharmaceutical Ingredient
The active ingredient in Luxiq is betamethasone valerate (2.1). Other catalogue entries containing betamethasone valerate include Betaderm (Betamethasone Valerate).
Excipients and Formulation Carriers
Film coatings, stabilizers, and inactive carriers vary by strength and manufacturer presentation. If you have a known allergy to lactose, dyes, sulfites, or specific preservatives, ask our pharmacist to check the exact excipient list for your selected package (2.1).
Cautions and important safety information
Contraindications
Contraindications Betamethasone valerate foam, 0.12% is contraindicated in patients who are hypersensitive to betamethasone valerate, to other corticosteroids, or to any ingredient in this preparation. (1.1)
Key Clinical Precautions
Before starting or continuing Luxiq, discuss your complete medical history with your healthcare provider. Key clinical cautions include (1.1):
- Blood pressure elevation: Monitor blood pressure regularly during treatment and inform your clinician if sustained increases occur.
- Discontinuation and withdrawal effects: Do not abruptly stop taking this medication without consulting your prescriber. Premature discontinuation or abrupt withdrawal can cause rebound symptoms, disease flare, or increased thrombotic or cardiovascular risk depending on the drug class.
Pregnancy, Lactation, and Special Populations
Pregnancy Category C Corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. Some corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. There are no adequate and well-controlled studies in pregnant women. Therefore, betamethasone valerate foam, 0.12% should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Drugs of this class should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time. (1.1)
Interactions
Always provide your prescribing physician and pharmacist with an up-to-date list of all prescription medications, over-the-counter products, vitamins, and herbal supplements you take before starting Luxiq (2.1).
Side effects
Like all medications, Luxiq can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (1.1):
- Pruritus (mild itching): Report any spreading rash, hives, or mucosal irritation to your healthcare provider.
- Application-site reactions: Mild redness, dryness, itching, stinging, or irritation at the treated skin area; applying only a thin layer as directed helps minimize local irritation.
Clinical Trial and Postmarketing Adverse Reactions
Adverse reactions The most frequent adverse event was burning/itching/stinging at the application site; the incidence and severity of this event were as follows: Incidence and severity of burning/itching/stinging Maximum severity Product Total incidence Mild Moderate Severe Betamethasone Valerate Foam n=63 34 (54%) 28 (44%) 5 (8%) 1 (2%) Betamethasone valerate lotion n=63 33 (52%) 26 (41%) 6 (10%) 1 (2%) Placebo Foam n=32 24 (75%) 13 (41%) 7 (22%) 4 (12%) Placebo Lotion n=30 20 (67%) 12 (40%) 5 (17%) 3 (10%) Other adverse events which were considered to be possibly, probably, or definitely related to betamethasone valerate foam, 0.12% occurred in 1 patient each; these were paresthesia, pruritus, acne, alopecia, and conjunctivitis. The following additional local adverse reactions have been reported with topical corticosteroids, and they may occur more frequently with the use of occlusive dressings. (1.1)
When to Seek Immediate Medical Attention
Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).
Storage and handling
Frequently Asked Questions About Luxiq
What is Luxiq and what active ingredient does it contain?
Luxiq is a skin care and dermatology products agent containing the active pharmaceutical ingredient betamethasone valerate. It is supplied for topical administration and requires a valid prescription where applicable.
How does Luxiq work in the body?
Luxiq (betamethasone valerate) works through targeted pharmacological pathways in its class (skin care and dermatology products agent) to support the clinical management of specified inflammatory, itchy, or flaky skin conditions.
What conditions is Luxiq prescribed to treat?
Luxiq is primarily indicated for specified inflammatory, itchy, or flaky skin conditions. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.
How should I take or use Luxiq?
Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Luxiq is administered via the topical route. Apply it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.
What are the most common side effects of Luxiq?
Commonly reported side effects of Luxiq include itching and a reaction at the treatment site. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.
What medications or substances can interact with Luxiq?
Share your full list of current prescription medications, over-the-counter products, and supplements with your prescriber and pharmacist so they can screen for any potential drug interactions.
Can Luxiq be used during pregnancy or breastfeeding?
If you are pregnant, planning to become pregnant, or breastfeeding, consult your prescribing physician before using Luxiq to weigh the clinical benefits and potential risks.
Do I need a prescription to buy Luxiq online from Canada?
Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Luxiq (Betamethasone) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).
Does Luxiq have a generic equivalent (Betamethasone) at a Canada pharmacy?
Currently, Luxiq (Betamethasone) is dispensed in our catalogue as a brand-name formulation. Check our Betamethasone active ingredient hub for updates as licensed generic presentations become available.
Other Brands: Betaderm, Betnovate, Celestone Soluspan, Diprosone, Topilene
How is Luxiq shipped to U.S. residents, and how much does shipping cost?
Luxiq ships in discreet protective packaging at a flat rate of $14.99 USD per order via Canada Post and USPS with full tracking (if combined in the same order with a cold-chain item, total shipping is $29.99 USD in a larger container). Once your valid prescription passes safety checks (<1 business day) and you respond to the mandatory licensed pharmacist consultation request via phone, voicemail, or text message, delivery takes 3 to 7 business days from Manitoba, Canada (or 7 to 14 business days from licensed partner pharmacies in the UK, Singapore, and Mauritius). You see and choose the country of origin before you pay, and your Visa, Mastercard, or Discover card is only charged when your order is ready to ship.
How can I send or transfer my Luxiq prescription, or ask about an unlisted strength?
You can upload a clear photo or PDF of your Luxiq prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to (844) 666 – 6819. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.
References & Official Sources
Clinical, pharmacological, and safety facts for Luxiq (Betamethasone Valerate) are compiled directly from official regulatory prescribing labels and primary biomedical databases:
- (1.1) Betamethasone Valerate. U.S. National Library of Medicine / U.S. Food and Drug Administration (DailyMed). Official U.S. FDA / DailyMed Structured Product Labeling (SPL). (Accessed 2026-10-29).
- (2.1) Health Canada Drug Product Database (DPD), Authorized Product Records. Health Canada / Government of Canada. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).
